Research programme: mucoregulators - Genaera

Drug Profile

Research programme: mucoregulators - Genaera

Latest Information Update: 08 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genaera Corporation
  • Class Small molecules
  • Mechanism of Action Mucin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Lung disorders

Most Recent Events

  • 30 Jul 2002 This programme is still in active development
  • 26 Apr 2001 MSI 1953 is one of Genaera's mucoregulator compounds
  • 28 Mar 2001 Magainin Pharmaceuticals is now called Genaera Corporation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top